1-10 of 10
Min Du
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation

Simon T. Abrams, Dunhao Su, Yasmina Sahraoui, Ziqi Lin, Zhenxing Cheng, Kate Nesbitt, Yasir Alhamdi, Micaela Harrasser, Min Du, Jonathan H. Foley, David Lillicrap, Guozheng Wang, Cheng-Hock Toh
Journal: Blood
Blood (2021) 137 (1): 103–114.
https://doi.org/10.1182/blood.2019002973
Published: 2021
Includes: Supplemental data
Journal Articles

Longer Follow-Up Of The Combination Of Clofarabine, Idarubicin, and Cytarabine (CIA) As Frontline Therapy For Patients Younger Than 61 Years With Newly Diagnosed Acute Myeloid Leukemia (AML)

Aziz Nazha, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Huang Xuelin, Sangbum Choi, Guillermo Garcia-Manero, MD, Elias Jabbour, MD, Gautam Borthakur, MD, Tapan M. Kadia, MD, Marina Konopleva, MD, PhD, Jorge E. Cortes, MD, Alessandra Ferrajoli, MD, Steven M. Kornblau, MD, Michael Andreeff, MD, PhD, Min Du, Mark Brandt, Stefan H. Faderl, MD
Journal: Blood
Blood (2013) 122 (21): 1451.
https://doi.org/10.1182/blood.V122.21.1451.1451
Published: 2013
Journal Articles

Clofarabine, Idarubicin, and Cytarabine (CIA) As Frontline Therapy for Patients <= 60 Years with Newly Diagnosed Acute Myeloid Leukemia (AML)

Aziz Nazha, Farhad Ravandi, MD, Hagop M. Kantarjian, MD, Xuelin Huang, PhD, Sangbum Choi, Guillermo Garcia-Manero, MD, Elias J. Jabbour, MD, Gautam Borthakur, M.D., Tapan M. Kadia, M.D., Marina Konopleva, MD, PhD, Jorge E. Cortes, MD, Alessandra Ferrajoli, M.D., Steven M. Kornblau, MD, PhD, Michael Andreeff, MD, PhD, Zeev Estrov, MD, PhD, Naval G. Daver, MD, Naveen Pemmaraju, M.D., Min Du, Mark Brandt, BS, Stefan Faderl, MD
Journal: Blood
Blood (2012) 120 (21): 43.
https://doi.org/10.1182/blood.V120.21.43.43
Published: 2012
Journal Articles

Clofarabine, Idarubicin, and Cytarabine (CIA) As Frontline Therapy for Patients Younger Than 61 Years with Newly Diagnosed Acute Myeloid Leukemia (AML)

Aziz Nazha, Farhad Ravandi, MD, Hagop M. Kantarjian, Guillermo Garcia-Manero, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Marina Konopleva, M.D., Ph.D., Jorge E. Cortes, Alessandra Ferrajoli, MD, Steven M. Kornblau, Michael Andreeff, M.D., Ph.D., Min Du, Mark Brandt, BS, Stefan Faderl, MD
Journal: Blood
Blood (2011) 118 (21): 1550.
https://doi.org/10.1182/blood.V118.21.1550.1550
Published: 2011
Journal Articles

Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism

Dunyaporn Trachootham, Hui Zhang, Wan Zhang, Li Feng, Min Du, Yan Zhou, Zhao Chen, Helene Pelicano, William Plunkett, William G. Wierda, Michael J. Keating, Peng Huang
Journal: Blood
Blood (2008) 112 (5): 1912–1922.
https://doi.org/10.1182/blood-2008-04-149815
Published: 2008
Includes: Supplemental data
Journal Articles

The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R–positive CLL cells

Ramadevi Nimmanapalli, Mi-Ae Lyu, Min Du, Michael J. Keating, Michael G. Rosenblum, Varsha Gandhi
Journal: Blood
Blood (2006) 109 (6): 2557–2564.
https://doi.org/10.1182/blood-2006-08-042424
Published: 2006
Journal Articles

Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial

Clinical Trials & Observations
Deepa Sampath, Jorge Cortes, Zeev Estrov, Min Du, Zheng Shi, Michael Andreeff, Varsha Gandhi, William Plunkett
Journal: Blood
Blood (2006) 107 (6): 2517–2524.
https://doi.org/10.1182/blood-2005-08-3351
Published: 2006
Journal Articles

A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine)

Varsha Gandhi, John M. Kilpatrick, William Plunkett, Mary Ayres, Leigh Harman, Min Du, Shanta Bantia, Jan Davisson, William G. Wierda, Stefan Faderl, Hagop Kantarjian, Deborah Thomas
Journal: Blood
Blood (2005) 106 (13): 4253–4260.
https://doi.org/10.1182/blood-2005-03-1309
Published: 2005
Journal Articles

Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias

Clinical Trials & Observations
Stefan Faderl, Varsha Gandhi, Susan O'Brien, Peter Bonate, Jorge Cortes, Elihu Estey, Miloslav Beran, William Wierda, Guillermo Garcia-Manero, Alessandra Ferrajoli, Zeev Estrov, Francis J. Giles, Min Du, Monica Kwari, Michael Keating, William Plunkett, Hagop Kantarjian
Journal: Blood
Blood (2005) 105 (3): 940–947.
https://doi.org/10.1182/blood-2004-05-1933
Published: 2005
Journal Articles

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia

Clinical Trials & Observations
Hagop Kantarjian, Varsha Gandhi, Jorge Cortes, Srdan Verstovsek, Min Du, Guillermo Garcia-Manero, Francis Giles, Stefan Faderl, Susan O'Brien, Sima Jeha, Jan Davis, Zeev Shaked, Adam Craig, Michael Keating, William Plunkett, Emil J Freireich
Journal: Blood
Blood (2003) 102 (7): 2379–2386.
https://doi.org/10.1182/blood-2003-03-0925
Published: 2003